2023
DOI: 10.1021/acsomega.3c01314
|View full text |Cite
|
Sign up to set email alerts
|

Discovery of a Hidden Trypanosoma cruzi Spermidine Synthase Binding Site and Inhibitors through In Silico, In Vitro, and X-ray Crystallography

Abstract: In drug discovery research, the selection of promising binding sites and understanding the binding mode of compounds are crucial fundamental studies. The current understanding of the proteins-ligand binding model extends beyond the simple lock and key model to include the induced-fit model, which alters the conformation to match the shape of the ligand, and the pre-existing equilibrium model, selectively binding structures with high binding affinity from a diverse ensemble of proteins. Although methods for det… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
4
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6
1

Relationship

2
5

Authors

Journals

citations
Cited by 10 publications
(4 citation statements)
references
References 88 publications
0
4
0
Order By: Relevance
“…Recent advances in deep learning models and their generalization capabilities have led to the development of generative models for de novo design and hit-to-lead optimization. [4][5][6][7][8] However, most of these methods only focus on "what to make" and do not sufficiently consider "how to make"; thus, these methods have difficulty in the generation of synthesizable molecules. 9 Chemists must search for candidates for synthetic experiments from the many compounds suggested by the generative models; this aspect is a significant barrier to moving to bench synthesis.…”
Section: Introductionmentioning
confidence: 99%
“…Recent advances in deep learning models and their generalization capabilities have led to the development of generative models for de novo design and hit-to-lead optimization. [4][5][6][7][8] However, most of these methods only focus on "what to make" and do not sufficiently consider "how to make"; thus, these methods have difficulty in the generation of synthesizable molecules. 9 Chemists must search for candidates for synthetic experiments from the many compounds suggested by the generative models; this aspect is a significant barrier to moving to bench synthesis.…”
Section: Introductionmentioning
confidence: 99%
“…In the third stage, the lead compound is optimized to maintain a favorable affinity and improve pharmacokinetics . Recently, target-to-hit and lead optimization stages have become more efficient owing to computational tools such as docking simulation, molecular dynamics (MD) simulation, and artificial intelligence. …”
Section: Introductionmentioning
confidence: 99%
“…It involves a series of steps beginning with the identification of biological targets, followed by the development of hit compounds, optimization of lead compounds, and finally, preclinical and clinical testing of drug candidates. 1 Hit compounds are compounds that show initial activity against target proteins involved in diseases, such as 3CL protease, 2 spermidine synthase, 3,4 dephospho-CoA kinase, 5 and nicotinamide adenine dinucleotide (NAD)-dependent deacetylase Sirtuin 1, 6 and have potential to be developed as drugs. Hit compounds are found through various screening methods, including high-throughput screening, which searches for targets from a large compound library.…”
Section: ■ Introductionmentioning
confidence: 99%
“…Hit compounds are compounds that show initial activity against target proteins involved in diseases, such as 3CL protease, spermidine synthase, , dephospho-CoA kinase, and nicotinamide adenine dinucleotide (NAD)-dependent deacetylase Sirtuin 1, and have potential to be developed as drugs. Hit compounds are found through various screening methods, including high-throughput screening, which searches for targets from a large compound library.…”
Section: Introductionmentioning
confidence: 99%